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Abstract Interleukin 1 (IL-I) potently activates human glo- 
merular mesangial cells (HMC). In cytosolic extracts of IL-1- 
stimulated HMC or in anion exchange chromatography fractions 
we could not find any change in phosphorylation of myelin basic 
protein (MBP), a good substrate for extracellular regulated 
kinase (ERK). In contrast, IL-I stimulated GST-jun kinase 
activity at least 10-fold. The jun kinase activity could be 
charaeterised as JNK1 and JNK2 at the protein and mRNA 
level. IL-I, TNF, UV light and osmotic stress, but not PMA, 
LPS, IL-3, IL-4, IL-6, IL-8, IL-10, IL-13, GM-CSF, PDGF, 
bFGF, TGF-[~ and interferon- T were able to stimulate jun kinase 
activity in HMC, suggesting that jun kinase is selectively 
mediating signal transduction of the proinflammatory cytokines 
IL-1 and TNF as well as of cellular stress in HMC. 
Key words: Interleukin; Jun N-terminal kinase; Human 
mesangial cell 
1. Introduction 
Activated human mesangium cells have been established to 
play an important role in glomerular inflammatory disease, 
including glomerulonephritis [1]. IL-1 and, to a lesser extent, 
TNF-c~ have emerged as the most potent activators of mesan- 
gial cells (MC). IL-1 induces the expression of several genes 
including growth factors (bFGF,  PDGF,  GM-CSF, M-CSF), 
cytokines (IL-1, IL-6), chemokines (IL-8, MCP-1), proteases 
and matrix components. Therefore, understanding the signal 
transduction mechanisms induced by IL-1 might be important 
to generate specific tools to alter mesangial cell function dur- 
ing pathological processes. Little information is available 
about signal transduction i  mesangial cells, mainly through 
studies on rat cells. It is important o notice that significant 
differences between human and rat MC exist (reviewed in [2]). 
For example, IL-1 can induce proliferation of rat mesangial 
cells [3], but not of human cells [4]. Intracellular protein ki- 
nases like the mitogen-activated protein kinases (MAPKs) are 
key molecules transducing extracellular signals into the nu- 
cleus [5]. Depending on the tissue or cell system studied IL- 
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1 has been shown to activate various MAP kinases [6-12]. The 
aim of the present study was therefore to investigate the reg- 
ulation of two major MAP kinase pathways, the jun or stress- 
activated protein kinases and the extracellular regulated ki- 
nases, by IL-1 in human mesangial cells. 
2. Materials and methods 
2.1. Materials 
Human recombinant IL-lot was expressed in E. coli and purified as 
described [7]. IL-I~ was a gift from Dr. Gallati, Hoffmann LaRoche, 
Basel, Switzerland; IFN-~/was donated by Dr. B. Otto, Fraunhofer 
Institute, Hannover, Germany; IL-3, IL-4, IL-13, TNF-c~, transform- 
ing growth factor [3-1 (TGF-131) and basic fibroblast growth factor 
(bFGF) were all from Pharma Biotechnologie, Hannover, Germany; 
IL-6 was a gift from Dr. W. Fiers, Gent, Belgium; IL-8 was from Dr. 
1. Lindley, Sandoz, Vienna, Austria; IL-10 was from Laboserv, Gies- 
sen, Germany; granulocyte-monocyte olony-stimulating factor (GM- 
CSF) was generously provided by Dr. K. Welte, Department of Pe- 
diatrics, Medical School, Hannover, Germany; platelet-derived 
growth factor (PDGF) was from Peprotech, London, UK); lipopoly- 
saccharide (LPS) from E. coli, E64 (trans-epoxysuccinyl-L-leucylami- 
do-(4-guanidino)butane), p pstatin, PMSF (phenylmethanesulphonyl 
fluoride) and all other chemicals were from Sigma, Deisenhofen, Ger- 
many. [~,-32p]ATP was purchased from Hartmann Analytic, Braun- 
schweig, Germany. 
The cDNA of the truncated jun protein comprising amino acids 1 
135 was a kind gift of Prof. C. Marshall, Institute for Cancer Re- 
search, Chester Beatty Laboratories, London, UK. The cDNA for 
GST p54 MAP kinase 13 was a kind gift of Dr. J.R. Woodgett (The 
Ontario Cancer Institute, Toronto, Ont., Canada). GST fusion pro- 
teins were expressed and purified from E. cob as glutathione S-trans- 
ferase fusion proteins [8]. The mouse anti-human JNK1 antibody 
(clone G151-333.8) was from Pharmingen, San Diego, CA, USA. 
The mouse pan anti-ERK antibody was from Transduction Labora- 
tories, Lexington, KY, USA. The chicken anti-p54 MAP kinase [3 
antibody was produced by immunising chicken with recombinant 
GST p54 MAP kinase !3 and purifying the immunoglobulins from 
egg white. 
2.2. Human glomerular mesangial cell culture 
HMC, isolated and characterised as described [4], were cultured in 
RPMI-1640 medium supplemented with nonessential amino acids, L- 
glutamine (2 mM), sodium pyruvate (2 mM), transferrin (5 [.tg/ml), 
insulin (125 U/ml) (all Life Technologies, Eggenstein, Germany) and 
10%, fetal calf serum (PAA laboratories, Linz, Austria). 
2.3. Stimulation and preparation of cellular extracts 
After mild trypsinisation, equal cell numbers (4× 10000 cells/well) 
of HMC were seeded in 24-well plates and grown to subconfluence. 
HMC were activated by adding stimuli to the culture medium and 
incubating the cells at 37°C, 5% CO2 for the indicated times. All 
further steps were carried out at 4°C. 
After stimulation the cells were washed in phosphate-buffered saline 
(PBS) and resuspended byscraping them in lysis buffer (20 mM Tris, 
pH 7.4, 1 mM EGTA, l mM EDTA, 0.2 mM Na3VO4, 50 mM NaF, 
2 mM dithiothreitol (DTT)) including protease inhibitors (10 [aM E64, 
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1 mM PMSF, 1 gM pepstatin). For MonoQ chromatography cells 
were broken mechanically by passaging them three times through a 
26-gauge needle. Broken cells were centrifuged at 100 000 x g at 4°C 
and the supernatants aken as cytosolic extract. Alternatively cells 
were lysed by adding 0.5% NP-40 to the lysis buffer and leaving 
them on ice for 20-30 min. Detergent lysates were cleared by centri- 
fuging them at 15 000 × g for 30 min at 4°C and supernatants collected. 
2.4. Protein kinase assays 
The assays were carried out in a reaction mixture (15 gl) containing 
5 gl of sample, 5 gl of GST-jun or MBP (0.5 1 I.tg) and 5 gl of 150 
mM Tris, pH 7.4, 30 mM MgCI2 and 60 p.M ATP (including 1-3 gCi 
of [732p]ATP. Assays were started by adding ATP and incubated at 
room temperature for 20 min. The phosphorylation reaction was ter- 
minated by adding 5/al of electrophoresis ample buffer (8% SDS, 100 
mM Tris, pH 6.8, 4% 13-mercaptoethanol, 24% glycerol, 0.02% bro- 
mophenol blue). The phosphorylated substrates were separated from 
the reaction mixture by SDS/PAGE and analysed by autoradiography 
as described [6]. Autoradiographs were quantitated using a GelDoc 
100 System and the Molecular Analyst Program (BioRad, Hercules, 
CA, USA). 
2.5. Western blotting 
Proteins were separated on SDS/PAGE and electrophoretically 
transferred to PVDF membranes (lmmobilon ® Millipore, Bedford, 
MA, USA). The membranes were blocked with 5% dried milk in 
Tris-buffered saline (TBS) for 30 min at 37°C. Membranes were 
then incubated for 4-24 h with chicken antibody raised against re- 
combinant GST p54 MAP kinase 13 protein or with the mouse anti- 
pan ERK antibody. Blots were washed in TBS, and incubated for 24  
h with the second antibody (rabbit anti-chicken or sheep anti-mouse, 
coupled to horseradish peroxidase, Sigma, Germany). Proteins were 
detected using the Amersham enhanced chemiluminescence (ECL) 
system. 
2.6. Immunoprecipitation 
A cytosolic extract from one 75-cm 2 flask of stimulated or un- 
treated confluent HMC was incubated with 1 gg mouse IgG1 for 
1 h. Then 20 gl of protein G sepharose was added and incubation 
carried out for another hour. Samples were spun in a microfuge for 10 
min and the precleared supernatant incubated with 0.5 gg of mouse c~- 
JNKI antibody for 2 h. Then 20 gl of protein G Sepharose beads 
were added for 1 h. Beads were pelleted in a microfuge, washed 5 × in 
PBS and 1 × in kinase reaction buffer and resuspended in 10 gl lysis 
buffer. Immunoprecipitated jun kinase activity was measured by add- 
ing 20 gl of kinase buffer including GST jun as described above. 
2. 7. Anion exchange chromatography 
Equal amounts of cytosolic protein from stimulated or unstimu- 
lated HMC (six 175-cm 2 flasks each) were loaded on to a MonoQ 
HR5/5 column run by a FPLC system (Pharmacia). The column was 
equilibrated in buffer A (20 mM Tris, pH 8.5, 20 mM !3-glycerophos- 
phate, 50 mM NaF, 0.1 mM Na3VO4, 2 mM DTT, 0.5 mM EGTA, 
0.5 mM EDTA). Proteins were eluted with a linear salt gradient (0 
0.5 M NaCI). 1-ml fractions were collected and assayed for kinase 
activity. 
2.8. Polymerase chain reaction 
Total cellular RNA from HMC was isolated with RNA clean 
(AGS, Heidelberg, Germany) followed by a LiC12 precipitation and 
determined spectrophotometrically. 1 gg of total RNA was reverse 
transcribed and amplification with 40 cycles of the resulting cDNA 
performed in a thermocycler Varius VR (Landgraf, Hannover, Ger- 
many) as described [2,11]. 15 gl of 100 gl PCR reaction mixture was 
restricted with Pstl or left untreated and analysed on 1.5% agarose 
gels. DNA-containing bands were visualised by ethidium bromide 
staining. Sequences for JNK primer pairs according to published se- 
quences for JNK1 (accession o. L 26318) and JNK2 (accession o. 
UO 9759): 
JNK1, sense (5'--3') : 
GCG CGG ATC CTT GCT TGC CAT CAT GAG CAG; 
JNK1, antisense (5 ' -3 ' )  : 
GCG CGG ATC CCA GAC GAC GAT GAT GAT GGA. 
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JNK2, sense (5 ' -3 ' )  : 
GCG CGG ATC CTG CAT CAT GAG CGA CAG TAA; 
JNK2, antisense (5 / -3  ') : 
GCG CGG ATC CAA CCT ATC ATC GAC AGC CTT. 
3. Resu l ts  
Initial experiments howed that IL-1 did not induce MBP 
phosphorylation i HMC (Fig. 1A,B). In cytosolic extracts of 
cells stimulated with bFGF or PMA increased MBP kinase 
activity was detected indicating that activation of the ERK 
group of MAP kinases can be measured under those condi- 
tions (Fig. 1C,D). 
In contrast IL-1 stimulated jun kinase activity l~15- fo ld  in 
comparison to untreated cells (Fig. 1A). IL-l-activated jun 
kinase activity was detectable after 5 min and peaked between 
15 and 30 min of stimulation. After 60 min activity was de- 
clining, but still detectable. Immunoprecipitation experiments 
identified JNK1 as one of the activated JNK  isoforms (Fig. 2) 
To investigate whether one or more isoforms of JNKs are 
present and activated in HMC we fractionated cytosolic ex- 
tracts from stimulated or untreated HMC on anion exchange 
chromatography (Fig. 3). Most of the jun kinase activity 
eluted from the column at 200-300 mM NaC1 (fractions 5- 
13) and was strongly regulated by IL-1 (Fig. 3A). This chro- 
matographic behaviour is typical for the stress-activated pro- 
tein kinases as we have shown during the purification of p54 
MAP kinase [7,8]. An anti-p54 MAPK-I3 antiserum, which 
cross-reacts with 50- and 55-kDa forms of p54 MAP-~ and 
45/46-kDa jun kinases in KB epidermal carcinoma and 
HepG2 hepatoma cells (M. Kracht, unpublished results) rec- 
ognised two major protein bands with molecular masses of 
about 46 and 55 kDa on SDS/PAGE in MonoQ fractions 
5-13 (Fig. 3B). The proteins comigrated with the jun kinase 
activity during chromatography. This strongly suggests that 
IL-1 activates two forms of jun  kinase activity in HMC.  They 
most likely represent JNK1 and JNK2 for which a Mr of 46 
and 55 kDa has been described. 
There was no change in total MBP phosphorylation i frac- 
tions 9-17 from extracts of untreated cells or IL-l-stimulated 
cells (Fig. 3C). The MBP kinase activity coeluted with the 42- 
kDa MAP kinase ERK2, which was detected by an anti-pan 
ERK antibody (Fig. 3D). 
The expression of JNK1 and JNK2 was further analysed by 
RT-PCR using specific primer pairs. As shown in Fig. 4, 
cDNAs of the expected size, 1250 bp for JNK1 and 1300 
bp for JNK2, were the only amplified PCR products. The 
identity of the cDNAs was confirmed by restriction of the 
PCR products with the endonuclease PstI, which cleaves 
only the JNK1 cDNA, generating fragments of 527 and 625 
bp. The results demonstrate that HMC express both mRNAs 
for JNK1 and JNK2. It is therefore likely that both kinases 
are activated by IL-1 in these cells. 
HMC respond to a very wide range of stimuli including 
growth factors, cytokines and chemokines. Thus they repre- 
sent an excellent system to study the selectivity of jun kinase 
activation in non-transformed primary cells. Therefore we as- 
sayed jun kinase activity upon stimulation with TNF,  UV 
light and osmotic shock (NaC1, sorbitol) as well as cytokines 
(IL-3, IL-4, IL-6, IL-8, IL-10, IL-13, IFN-7, TGF-I]), tumor 
promoters (PMA), bacterial cell wall products (LPS) and 
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Fig. 1. IL-I stimulates c-jun but not MBP kinase activity in cytosolic extracts of HMC. HMC were stimulated with IL-I~ (20 ng/ml) for the in- 
dicated times. Then cytosolic extracts were prepared and jun and MBP kinase activity measured. A region of the autoradiogramm visualising 
substrate phosphorylation (A) and quantitation of the increase in substrate phosphorylation for jun ($) and MBP (• )  in comparison to un- 
treated cells is shown (B). HMC were also stimulated with IL-II3 (20 ng/ml), PMA (100 ng/ml) and bFGF (10 ng/ml) for 20 min and MBP ki- 
nase activity in cytosolic extracts measured. The phosphorylated proteins were separated on SDS/PAGE and detected by autoradiography (C) 
and quantitated (D). See Section 2 for details. 
growth factors (GM-CSF, PDGF,  bFGF).  As shown in Fig. 
5, only IL-1 and TNF, and the cell-stressing agents UV light, C [L" I  
sorbitol and NaC1 were able to stimulate jun kinase activity. 
The simultaneous activation by IL-1 and growth factors like ~ I 
PDGF or FGF  had no additive or synergistic effect on IL-I- ~., - -  
induced jun kinase activation, nor did activation by osmotic 
stress (NaC1 or sorbitol) and IL-1 together. 
4. Discuss ion 
There is good evidence that IL-1 can activate the p42/p44 
ERK group of MAP kinases in rat mesangial cells, based on 
immunoprecipitation experiments and gel kinase assays with 
MBP as substrate [13,14]. Activated ERKs are thought to 
play a role in cell proliferation by using overexpression of 
dominant negative mutants or antisense RNA [15,16]. In con- 
trast we could not measure increased MBP kinase activity in 
cytosolic extracts or in MonoQ fractions of IL-l-stimulated 
human mesangial cells under conditions where the phorbol 
ester PMA or bFGF did induce MAP kinase activity. The 
lack of ERK activation by IL-1 is consistent with our obser- 
vation that IL-1 is not a growth factor for human mesangial 
cells [4]. 
In this report we demonstrate for the first time that IL-1 is 
a potent inducer o f jun  kinases in HMC. Two protein kinases 
W 
kD 
-94  
-67  
- -43  
-- 30 
GST-jun 
Fig. 2. The IL-l-stimulated jun kinase activity can be immunopreci- 
pitated with an antibody against JNK1. HMC were stimulated for 
20 min with IL-lo~. Cells were lysed and jun kinase activity was 
measured in immunoprecipitates as described in Section 2. The 
phosphorylated jun protein was separated on SDS/PAGE and de- 
tected by autoradiography. 
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Fig. 3. Identification of jun kinases and extracellular regulated kinases in anion exchange chromatography fractions from resting or stimulated 
HMC. HMC were stimulated with IL- la for 20 min or left untreated. A cytosolic extract was prepared. Equal amounts of protein were than 
loaded on to a MonoQ column and eluted with a linear salt gradient (0~).5 M NaC1) in 20 fractions of 1 ml. A: Jun kinase activity was meas- 
ured in aliquots of fractions. B: Proteins from 50 gl of each fraction were separated on SDS/PAGE, transferred to membranes and probed 
with an antibody against GST p54 MAPK 13. C: MBP kinase activity in aliquots of the fractions. D: Proteins from 50 gl of each fraction 
were separated on SDS/PAGE, transferred to membranes and probed with an antibody against ERKs. Chromatography, protein kinase assays, 
separation of phosphorylated proteins on SDS/PAGE, detection by autoradiography and Western blotting were performed as described in Sec- 
tion 2. ST = material loaded on to the column, RT = material that did not bind to the column. 
with a Mr of 46 and 55 kDa were identified by specific anti- 
bodies. They are very likely to represent the two human iso- 
forms of stress-activated protein kinases, JNK1 and JNK2, 
since we could also detect the mRNA of both these kinases. 
Identifying as precisely as possible JNK  or SAPK isoforms 
expressed and activated within a cell or tissue is important,  
since it is unclear whether isoforms can display functional 
differences. Several isoforms of JNKs  or SAPKs have been 
cloned or purified so far. In the rat three genes, encoding p54 
MAP kinase c~, 13, and 1,, and alternatively spliced variants 
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Fig. 4. HMC express mRNA for JNK1 and JNK2. RNA from 
HMC was isolated and RT-PCR with primer pairs specific for 
JNKI (a) and JNK2 (b) performed as described in Section 2. The 
resulting PCR products were left untreated ( - )  or digested with 
PstI (+) and separated on a 1.5% agarose gel. A photography of 
the ethidium bromide-stained gel is shown, JNK1 and JNK2 
cDNAs are indicated by arrows. DNA size markers (¢174 DNA di- 
gested with HaeI) are shown in the left lane. 
4- -  
have been cloned [17]. Up to now two human cDNAs encod- 
ing JNK I  and JNK2 have been cloned [18,19]. All genes are 
highly homologous and encode proteins with a molecular 
mass between 46 kDa (JNK1, p54 MAP kinase y) and 5a5 
kD (JNK2, p54 MAP kinase o~ and ~3) when expressed in COS 
cells. Recently we purified from rat liver two 50- and 55-kDa 
forms of IL-l-activated p54 MAP kinase a [8] and an IL-1- 
activated 46-kDa SAP kinase from the human epidermal cell 
line KB [7]. 
In agreement with our data one recent report describes the 
activation of two jun kinases by IL-1 and protein synthesis 
inhibitors in rat MC [20]. The kinases were detected in gel 
kinase assays but not further characterised, and their relation 
to the cloned rat enzymes (see above) remains unclear. 
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Fig. 5. Selective activation of jun kinase activity by IL-1, TNF and stress in HMC. Confluent HMC were left untreated (C) or stimulated for 
15 rain with the following stimuli: IL-I~3 (20 ng/rnl), TNF-ct (1000 U/ml), NaC1 (400 mM), sorbitol (500 mM), UV light (312 rim), IL-3 (50 ng/ 
ml), IL-4 (10 ng/ml), IL-6 (1 ng/ml), IL-8 (50 ng/ml), IL-10 (50 ng/ml), IL-13 (10 ng/ml), interferon-'/(IFN-y, 500 U/ml), GM-CSF (50 ng/ml), 
LPS (10 ktg/ml), PMA (100 ng/ml), bFGF (10 ng/ml), PDGF (10 ng/ml), TGF-[~ (50 ng/ml) and the combinations of IL-I[~ with bFGF, 
PDGF; NaC1 or sorbitol. After stimulation cells were lysed with NP-40 and jun kinase activity measured. Phosphorylated jun protein was sepa- 
rated on SDS/PAGE. a2p incorporated into jun substrate was visualised by autoradiography and quantitated as described in Section 2. Shown 
is the increase in jun phosphorylation i duced by the different stimuli compared to untreated cells from three independent experiments. 
278 P. Ueiechowski et al./FEBS Letters 394 (1996) 273~78 
In an extension of our study we were also interested in the 
effects of other extracellular stimuli which can act on HMC 
and for which the expression of receptors has been shown. 
Very interestingly TNF, osmotic stress and UV light were 
the only other stimuli that were effective in activating jun 
kinase. To our knowledge this is the only study where such 
a wide range of cytokines has been tested for the ability to 
activate jun kinases. 
The combination of IL-1 and bFGF synergistically induces 
PGE2 synthesis and secretion of chemokines like RANTES, 
MCP-1 and IL-8 (P. Uciechowski, M. Schwarz, V. Kaever, K. 
Resch and H.H. Radeke, manuscript in preparation). How- 
ever, we did not observe any effect of bFGF or PDGF on IL- 
l-induced jun kinase activation. Both growth factors activate 
the classical MAP kinase cascade in rat MC, as has been 
shown by activation of raf, MAP kinase and ERK2 [21]. 
The synergistic action of IL-1 and for example bFGF on 
gene expression in human MC could therefore be a result of 
the convergence of different MAP kinase pathways, rather 
than enhanced activation of the same pathway. 
In summary, we present evidence that a novel MAP kinase 
pathway is activated in HMC by IL-1, involving JNK1 and 
JNK2. We also show that IL-I does not activate the ERK 
group of MAP kinases in these cells. The striking selectivity of 
JNK activation by IL-I and TNF  potentially makes this pro- 
tein kinase pathway a target for pharmacological intervention, 
at least in those inflammatory or stress-dependent pathologi- 
cal processes of the kidney where glomerular mesangial cells 
are involved. 
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